Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJXF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,281
Award facts
- Contract value 100% obligated
- $5,281.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,281.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The award, issued on December 15, 2025, with an ultimate completion date of January 7, 2026, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion enterprise-wide acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a critical supplier within the military pharmaceutical supply chain, with its parent indefinite delivery contract—designated SPE2DR and valued at $499,999,999—established through November 13, 2025, and extending through December 31, 2036. The contract structure encompasses a 30-month base period with three 30-month option periods, authorizing the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. The vendor's established performance across numerous prior delivery orders spanning multiple therapeutic categories positions it as a capable regional prime vendor contractor supporting the Department of Defense's global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJXF2?
SPE2DR26FJXF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FJXF2 worth?
The government has obligated $5,281 on SPE2DR26FJXF2.
Is contract SPE2DR26FJXF2 an order under another contract?
Yes. SPE2DR26FJXF2 is a delivery order under SPE2DR25D9307, an indefinite delivery contract.
Was contract SPE2DR26FJXF2 competed?
The extent of competition for SPE2DR26FJXF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award